☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
caliway biopharmaceuticals
Caliway Biopharmaceuticals’ CBL-514 Receives the EMA’s Orphan Drug Designation for the Treatment of Dercum’s Disease
November 13, 2024
Caliway Reports the IND Acceptance of CBL-514 by the US FDA for the Treatment of Dercum's Disease
January 8, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.